Background Patients with asthma show altered surface expression of the adhesion molecules CD11b and L-selectin on airway granulocytes compared with blood granulocytes. Objective To investigate whether this modulation is related to disease activity or due to transendothelial migration, we compared the CD11b and L-selectin expression on blood and induced sputum eosinophils and neutrophils between patients with asthma and normal subjects. Methods Eleven normal subjects (21-43 years), nine patients (21-34 years) with mild atopic asthma and 10 patients (20-47 years) with moderate to severe atopic asthma on regular treatment with inhaled steroids underwent sputum induction by inhalation of nebulized hypertonic saline (4.5%). CD11b and L-selectin expression on granulocytes from blood and DTT-homogenized sputum were analysed by flow cytometry. Eosinophils could be discriminated from neutrophils by using depolarized light scatter. Disease activity was assessed by baseline FEV 1 and airway responsiveness to histamine (PC 20 ). Results Sputum eosinophils showed higher expression of CD11b (P < 0.001) and lower expression of L-selectin (P < 0.001) compared with peripheral blood eosinophils. CD11b and L-selectin expression on eosinophils from blood or sputum did not differ between the three groups. Similar results were obtained for neutrophils. The PC 20 in the patients with moderate-to-severe asthma was related to CD11b expression on blood (R ¼ -0.92, P ¼ 0.001) and sputum eosinophils (R ¼ 0.75, P ¼ 0.02). Conclusions Flow cytometry of induced sputum granulocytes from asthmatic as well as normal subjects is feasible. We conclude that the modulated expression of CD11b and L-selectin on airway granulocytes is not specific for asthmatic airway inflammation, but is probably the result of tissue migration per sé. This implies that CD11b and L-selectin expression on granulocytes in induced sputum cannot be used as marker of disease activity.
Introduction
Chronic airway inflammation in bronchial asthma is associated with the presence of eosinophils in bronchial tissue and epithelial lining fluid [1] [2] [3] . It has been shown that eosinophils derived from spontaneous produced sputum and bronchoalveolar lavage (BAL) from patients with asthma have increased surface expression of CD11b and decreased surface expression of L-selectin compared with peripheral blood eosinophils [4] [5] [6] [7] [8] [9] . This (change of the) surface expression of the adhesion molecules CD11b and L-selectin on the eosinophil is thought to be a marker of cell activation [10] [11] [12] and seems to be influenced by migration of eosinophils from peripheral blood to the site of inflammation in tissues.
Two initial phases in the process of migration, similar for eosinophils and neutrophils, can be recognized [13] . During the so-called 'rolling adhesion' several adhesion molecules, among which L-selectin, on the surface of the eosinophil bind to their endothelial ligands [13] [14] [15] [16] . Hereafter, the CD11b b 2 -integrin adhesion molecule (Mac-1, CR3) binds to its ligand on the endothelial cell, while CD11b expression on the surface of the eosinophil is rapidly increased from intracellular storage pools [13] [14] [15] [16] [17] . One of the endothelial ligands for CD11b has been identified as the intercellular adhesion molecule-1 (ICAM-1). During this 'firm adhesion' L-selectin is shed from the surface of the eosinophil [13] [14] [15] [16] .
It is, however, not known whether the modulated expression of these adhesion molecules on airway granulocytes is implicit to the process of migration, or whether the extent of modulation is also associated with disease activity [4, 6, 18] . If the extent of modulation is affected by disease activity, the change in expression of the adhesion molecules will differ between patients with asthma and normal subjects.
The induction of sputum by inhalation of hypertonic saline has been introduced as a relatively non-invasive and safe method to study asthmatic airway inflammation [19] . Differential cell counts as well as fluid phase measurements obtained from induced sputum have been shown to be reproducible and seem to correlate with other indices of asthma severity [19] [20] [21] [22] . Recently, more sophisticated techniques like polymerase chain reaction (PCR) of sputum and flow cytometric analysis of sputum lymphocytes have been performed successfully [23] [24] [25] .
The aim of the present study was to investigate whether the change in CD11b and L-selectin expression on eosinophils and neutrophils in blood vs airways differed between patients with asthma and normal subjects. Secondly, we aimed to assess the feasibility of flow cytometric analysis of induced sputum to answer this question. Therefore, we measured the expression of these adhesion molecules on eosinophils and neutrophils in peripheral blood and induced sputum obtained from three groups of subjects: a group of normal subjects; a group of patients with mild asthma, only treated with short-acting b 2 -agonists on demand; and another group of patients with moderate-tosevere asthma treated with inhaled corticosteroids. Subsequently, we compared the difference in expression of adhesion molecules on eosinophils from sputum vs blood and assessed the relationship of the expression of adhesion molecules with asthma severity as measured by FEV 1 and airway responsiveness.
Methods

Subjects
Nine subjects with mild atopic asthma (two female and seven male), aged 21-34 years, 10 subjects (three female and seven male) with well-controlled, moderate-to-severe atopic asthma, aged 20-47 years, and 11 healthy non-atopic, non-asthmatic subjects (three female and eight male), aged 23-43 years, participated in the study (Table 1 ). All subjects were non-smokers or ex-smokers (for more than 12 month, with less than 5 pack-years). All asthmatic subjects had a history of episodic dyspnoea, wheezing and reversible airway obstruction. Severity of asthma was classified according to the international guidelines [26] . Atopic status was evaluated by skin-prick tests (Soluprick, ALK, Denmark). The FEV 1 was within the normal range (> 70% predicted) at baseline, or after inhalation of 400 mg salbutamol using a metered dose inhaler connected to an aerosol chamber [27] . Airway hyperresponsiveness to histamine, as shown by a provocative concentration to cause a 20% fall in FEV 1 (PC 20 ) of less than 8 mg/mL [28] , was confirmed in the patients with asthma and excluded in the normal subjects. All asthmatic subjects were treated with inhaled short acting b 2 -agonists on demand. The subjects with moderateto-severe asthma also required regular therapy with inhaled corticosteroids (beclomethasone dipropionate or budesonide 200-1000 mg bid). One subject also used slow release theophylline. None of the subjects had a history of other disease than asthma, or used any other medication. The subjects were not studied within 4 weeks after a respiratory tract infection. The study was approved by the Hospital Medical Ethics Committee, and informed consent was given by all subjects. 
Design
On a screening day inclusion criteria were checked. Hereafter, subjects attended the laboratory between 08.00 and 10.00 h and underwent spirometry followed by a sputum induction procedure. Treatment with inhaled short acting b 2 -agonists was withdrawn at least 8 h, and slow-release theophylline at least 36 h before the study. Peripheral blood and induced sputum were obtained on the same occasion. 
Antibodies and reagents
Phycoerythrin (PE)-conjugated IgG2a monoclonal antibo- dies against CD11b, L-selectin (CD62 L)
Sputum induction
Sputum induction was performed by a validated method [22] . Sodium chloride aerosols 4.5% (w/v) were generated at room temperature by an ultrasonic nebulizer (DeVilbiss Ultraneb 2000, Somerset, PA, USA) with a calibrated particle size (mass median aerodynamic diameter 4.5 mm), with the output set at maximal (2.5 mL/min). The aerosols were administered to the subjects through a 100 cm long tube with an internal diameter of 22 mm, and were inhaled by mouth through a two-way valve (No. 2700; Hans-Rudolph, Kansas City, MO, USA), while the nose was clipped. FEV 1 was measured by standardized spirometry [27] before inhalation of the hypertonic saline. For safety reasons all subjects received salbutamol 400 mg via a metered dose inhaler (MDI) connected to an aerosol chamber. Hypertonic saline aerosols were inhaled in 5 min periods for a maximum of 30 min. Following every inhalation period, subjects were asked to rinse their mouth with water. If necessary the nose was blown. Hereafter the subjects were encouraged to cough and to expectorate sputum into a clean plastic container. The procedure was discontinued if an adequate amount (at least 1 g) was obtained or if the subjects experienced discomfort.
Sputum processing
The volume of the induced sputum sample was determined, and an equal volume of DTT 0.1% was added. The samples were mixed gently by a vortex mixer and placed in a shaking water bath at 37 ЊC for 15 min to ensure complete homogenization. The homogenized sputum was centrifuged at 1400 rpm for 10 min. The supernatant was aspirated, the pellet was resuspended in PBS and filtered through a nylon gauze (pore size 1 mm). Total cell counts were determined with a standard haemacytometer and viability of non-squamous cells was assessed by trypan blue exclusion. Cytospins were made [22] , stained with May-Grünwald-Giemsa, and differential cell counts were performed by counting 500 sputum cells. Samples with more than 80% squamous cells were excluded from analysis. Eosinophil cationic protein (ECP) levels in sputum supernatant were determined by fluoro-enzyme immunoassay (Pharmacia, Uppsala, Sweden). In order to investigate the effect of sputum handling on cell surface expression of CD11b and Lselectin, EDTA anticoagulated blood was also incubated with DTT in a shaking water bath at 37 ЊC for 15 min.
Immunofluorescence staining
Aliquots (100 mL) of EDTA-anticoagulated blood, with and without DTT pretreatment, and sputum samples were stained with saturating concentrations of monoclonal antibodies for 30 min at 4 ЊC in the dark (200 000-300 000 nonsquamous cells per antibody staining). After washing with ice-cold washing solution and centrifugation (1000 g, 2 min, 4 ЊC), the cells were fixed with 0.05% formaldehyde for 10 min at 4 ЊC in the dark [10] . Sputum cells were washed twice with ice-cold washing solution, resuspended in washing solution and kept at 4 ЊC in the dark pending further analysis. After lysis of erythrocytes in the blood samples with ice-cold lysis buffer, also these samples were washed twice, resuspended and kept at 4 ЊC in the dark. Flow cytometric analysis was performed within 6 h after staining.
Flow cytometric analysis
Flow cytometry was performed using a FACStar (Becton Dickinson) with Argon-ion laser (wavelength: 488 nm, power: 200 mW, sort rate: 1000 event/s). Gains were calibrated before each experiment to ensure that values were comparable between experiments. Because of an expected lower number of eosinophils, 20 000 events were analysed from each sample of the mild asthmatic and normal subjects, while 10 000 events were analysed from each sample of the moderate-to-severe asthmatic patients.
Granulocytes were gated by their forward and side light scattering characteristics. Furthermore, eosinophils were discriminated from neutrophils by using depolarized orthogonal light scattering [10, 29] . These scatter gate settings 
Statistical analysis
Unless otherwise stated, data are expressed as mean Ϯ standard error of the mean (SEM). PC 20 histamine was logtransformed before statistical analysis and is expressed as geometric mean Ϯ SEM in doubling doses. Fluorescence data are expressed as median [range] . Differences were analysed by Wilcoxon matched-pairs signed-ranks test and KruskalWallis 1-way ANOVA. Correlation (R) was assessed by Spearman correlations test. At a P-value of 0.05 or less, differences were considered to be statistically significant.
Results
Subject characteristics
Subject characteristics are summarized in Table 1 . There was no significant difference in age between the groups.
Baseline FEV 1 expressed as percentage predicted differed significantly between the three groups (P ¼ 0.001). In addition, the patients with moderate-to-severe asthma were significantly more responsive to histamine compared with the patients with mild asthma (P ¼ 0.007).
Total cell counts, cell differentials and cell viability
Total eosinophil count and percentage of eosinophils in leukocyte differential cell count in peripheral blood were significantly increased in both asthmatic groups compared with the normal subjects ( Table 2) . During the sputum induction none of the subjects experienced discomfort. No significant difference between the three groups was observed with respect to total cells per mL sputum, sputum differential cell counts and viability of non-squamous sputum cells ( Table 2 ). The apparent difference in the percentage of eosinophils in sputum between patients with moderate-to-severe asthma compared with the two other 
* P<0.01 vs normal. ) compared with blood granulocytes for normal subjects and patients with mild and (moderate-to-)severe asthma. The expression of these adhesion molecules on blood and sputum granulocytes did not differ between the groups. The expression of CD11b was increased and L-selectin was decreased on sputum granulocytes compared with blood granulocytes (ns, not significant). Table 3 . Specific log mean fluorescence data of CD11b and L-selectin on peripheral blood and induced sputum granulocytes. The expression in CD11b and L-selectin did not differ significantly between normal subjects, patients with mild and moderate-to-severe asthma in blood or sputum.
Eosinophils Neutrophils groups did not reach statistical significance. ECP levels in sputum from patients with mild asthma (276 ng/mL, range 10.4-598) and moderate-to-severe asthma (121 ng/mL, range 4-790) were higher as compared to the levels in sputum of normal subjects (40.6 ng/mL, range 4-264, P ¼ 0.02 and P ¼ 0.08, respectively). Sputum from one mild asthmatic subject was excluded because of a high percentage (> 80%) of squamous cells; in addition one sputum sample from the moderate-to-severe asthmatic group could not be evaluated because of interfering autofluorescence.
Discrimination of eosinophils and neutrophils from induced sputum by flow cytometry
We confirmed that the depolarized orthogonal light scattering technique allows separate analysis of eosinophils and neutrophils from induced sputum. With flow cytometric sorting experiments we obtained highly purified samples of almost 95% of sputum eosinophils and neutrophils, respectively (Fig. 3 ).
Eosinophil and neutrophil expression of CD11b and L-selectin in asthmatic and normal subjects
Background fluorescence of eosinophils and neutrophils was slightly but significantly increased (P < 0.004) in induced sputum (18. Fig. 4 and Table 3 . The CD11b surface expression on either eosinophils or neutrophils in peripheral blood and induced sputum, respectively, did not differ between the three groups. Neither was there a difference between normal subjects, patients with mild asthma or with moderate-tosevere asthma with respect to the L-selectin expression on eosinophils and neutrophils in peripheral blood and induced sputum. For all three groups the CD11b expression on eosinophils and neutrophils in sputum was higher (groups separately: all P < 0.02, three groups combined: P < 0.001), and the L-selectin expression on both eosinophils and neutrophils was lower (groups separately: all P < 0.04, three groups combined: P < 0.001), compared with the expression on peripheral blood granulocytes.
The difference in surface expression of CD11b (dCD11b) and L-selectin (dL-selectin) in sputum vs peripheral blood eosinophils did not differ between the three groups (dCD11b: P ¼ 0.85, dL-selectin: P ¼ 0.49). However, the difference in CD11b expression on neutrophils in sputum vs. blood appeared to be less in the patients with mild asthma compared with the normal subjects and patients with moderate-to-severe asthma (dCD11b: P ¼ 0.02). No difference was observed in the difference in expression of L-selectin on neutrophils in sputum vs peripheral blood (dL-selectin: P ¼ 0.11).
Effects of DTT on surface expression of CD11b and L-selectin on eosinophils and neutrophils
There was no change in CD11b expression on eosinophils or neutrophils between DTT-pretreated blood (33. 
Relation between modulation of CD11b and L-selectin surface expression on eosinophils and FEV 1 , PC 20 histamine, or ECP
The blood eosinophil expression of CD11b of the patients with moderate-to-severe asthma was closely related with the baseline FEV 1 (R ¼ ¹ 0.83, P ¼ 0.005) and the PC 20 histamine (R ¼ ¹ 0.92, P ¼ 0.001). In addition, the PC 20 of patients with moderate-to-severe asthma was correlated with the expression of CD11b on sputum eosinophils (R ¼ 0.75, P ¼ 0.02) as well as with dCD11b on eosinophils in induced sputum vs peripheral blood (R ¼ 0.85, P ¼ 0.004) (Fig. 5) . No correlation was found for the L-selectin expression on blood nor sputum eosinophils. Furthermore, no correlations were observed between expression of adhesion molecules on eosinophils and FEV 1 or PC 20 in the mild asthmatic subjects. ECP levels in sputum from the patients with moderate-to-severe asthma, but not from the normal subjects and the patients with mild asthma, correlated inversely with the expression of CD11b on sputum eosinophils (R ¼ ¹ 0.68, P ¼ 0.042) as well as with dCD11b on eosinophils in induced sputum vs peripheral blood (R ¼ ¹ 0.70, P ¼ 0.036).
Discussion
The results from the present study indicate that patients with atopic asthma and non-atopic control subjects do not differ with respect to the CD11b and L-selectin surface expression on eosinophils and neutrophils in peripheral blood and induced sputum. This suggests that the altered expression of these adhesion molecules on sputum granulocytes compared with blood granulocytes is not related to exposure to inflammatory mediators specific for asthma, but is rather due to factors associated with migration.
Our results confirm and extend the findings of other investigators, who could not reveal differences in the unstimulated surface expression of CD11b on eosinophils and neutrophils in peripheral blood between asthmatics and normal controls [10, 30, 31] . The present study demonstrates that in addition to CD11b, also L-selectin expression on these cells does not differ between patients with asthma and normal subjects. Earlier studies in BAL or spontaneous sputum from atopic asthmatics demonstrated that the expression of CD11b is increased and that of L-selectin is decreased on airway eosinophils and neutrophils compared with peripheral blood granulocytes [4] [5] [6] [7] [8] [9] . In one study by Georas et al., the modulation of surface expression of CD11b and L-selectin was compared between BAL neutrophils recovered after segmental allergen challenge and saline challenge in four allergic asthmatic subjects [4] . There appeared to be no difference in the degree of surface marker modulation, suggesting a mechanism unrelated to allergen-induced airway inflammation. Our results are in agreement with the latter finding, showing that the altered surface expression of CD11b and L-selectin on eosinophils obtained from sputum vs peripheral blood is similar in patients with asthma and normal subjects.
This report is the first to show that flow cytometric analysis of granulocytes derived from induced sputum obtained from asthmatic as well as normal subjects is feasible. Earlier publications concerning flow cytometric analysis of granulocytes originating from the airways focused on cells obtained by BAL [4, 8, 9] or spontaneous produced sputum [5] . The advantage of our method is that it allows the comparison between asthmatic and normal subjects who do not produce sputum spontaneously.
In theory, several methodological factors could have influenced surface marker expression of CD11b and L-selectin on sputum granulocytes. These include insufficient quality or amount of induced sputum, inadequate technique of sputum induction and handling, and purification and discrimination procedures of the cells before and during flow cytometry. With the sputum induction technique that we used in our study [22] , both patients with asthma and normal subjects were able to produce and expectorate large enough sputum samples, with satisfactory cell viability from the subglottic area. No difference in percentage sputum eosinophils was observed between normal subjects and patients with mild asthma, which might be explained by the fact that the latter group was studied during a stable, symptom free episode. Nevertheless, eosinophil-derived ECP levels in sputum were significantly higher in the mild asthmatic patients as compared to the normal subjects. As whole sputum samples were used in stead of plugs, salivary contamination, reflected by the percentage squamous cells, was inevitable but comparable between the groups. Sputum samples were homogenized and filtered. Therefore, blockage of the flow cytometer was observed only occasionally and appeared to be minor. The inhalation of hypertonic saline itself could have accounted for the identical modulation of the adhesion molecules. Although this cannot be excluded entirely, there are no indications that hypertonic saline induces inflammatory changes in the airway wall responsible for modulation of adhesion molecules [32] . In addition, electron microscopic analysis of human basophils after hyperosmolar stimulation in vitro has failed to reveal either cell membrane disruption or other signs of cytotoxicity [33] . It is unlikely that sputum handling with DTT is responsible for the altered expression of adhesion molecules. CD11b expression was similar for DTT pretreated blood granulocytes and directly stained blood granulocytes, also indicating that incubation of DTT pretreated sputum at 37 ЊC does not further modulate CD11b expression. The L-selectin expression on peripheral blood granulocytes was even increased after DTT pretreatment, in contrast to the reduced expression on sputum granulocytes. The technique of discriminating neutrophils and eosinophils by using depolarized orthogonal light scattering [29] permits analysis of eosinophils from blood as well as sputum (Figs 1 and  3) without the need for purification procedures that could have altered surface expression. Finally, it could be argued that the power of the study was not sufficient to certainly exclude a difference in eosinophil adhesion molecule expression between the three groups. In retrospect however, the sample size was large enough to allow a detection of a 50% reduction in eosinophil adhesion molecule modulation
The results of our study, showing a similar change in eosinophil adhesion molecule expression in sputum compared with blood from asthmatic and normal subjects, can be explained by earlier in vitro experiments, in which adhesion molecule expression was studied during cell migration [6, 18] . In these experiments, an increase in CD11b expression on eosinophils accompanied by shedding of L-selectin was observed after migration through endothelial monolayers, and seemed to be a direct result of the interaction of eosinophils and endothelial cells. Our results fit in with these observations, in which tissue migration itself is inevitably associated with modulation of the adhesion molecules CD11b and L-selectin, independent of the stimulus that provokes the tissue migration. In this respect, the reduced modulation of CD11b on neutrophils of patients with mild asthma cannot be explained without any difficulty, and might just be the coincidental result of a slightly higher blood and slightly lower sputum CD11b expression. CD11b expression on peripheral blood eosinophils from the patients with moderate-to-severe asthma was closely, but inversely related to baseline FEV 1 as well as to airway responsiveness to histamine. It is unclear why, despite this correlation, there is no difference in CD11b expression on peripheral blood eosinophils between the groups. Finally, although we did not observe differences in surface expression of CD11b and L-selectin expression between atopic asthma patients and nonatopic control subjects, differences in the activity of these molecules may exist.
As peripheral blood eosinophils from asthmatics have been shown to be primed [10, 34] , the level of CD11b expression on blood eosinophils in this subgroup of asthmatics might reflect the preactivation or priming status of these cells. Extrapolating earlier reports, in which CD11b upregulation on eosinophils appeared to be indicative of cell activation [11] , we would expect also a negative correlation between sputum eosinophil CD11b expression and airway responsiveness. Surprisingly, a close, but positive correlation was observed in the group with moderate-to-severe asthma, indicating that an increase in hyperresponsiveness is associated with a reduction in upregulation of CD11b. A possible, but speculative explanation might be that ongoing activation of airway eosinophils results in massive degranulation accompanied by masking of relevant epitopes of surface CD11b, or shedding of CD11b adhesion molecules from the cell membrane. Whereas microscopic evaluation of the cytospin preparations did not reveal signs of massive degranulation of sputum eosinophils, the inverse relation between the upregulation of CD11b on sputum eosinophils and ECP levels in the induced sputum samples supports this hypothesis.
In summary, we demonstrated that sputum induction by inhalation of nebulized hypertonic saline is a safe and valid technique to study the expression of surface markers by flow cytometry on eosinophils and neutrophils from the airways of both patients with asthma and normal subjects. The surface expression of CD11b is upregulated and the surface expression of L-selectin is downmodulated on eosinophils and neutrophils from induced sputum compared with peripheral blood. There appeared to be no difference between patients with stable or moderate-to-severe atopic asthma and normal subjects, suggesting that the modulated expression of surface markers is not specific for the asthmatic airways inflammation, but is probably the result of tissue migration itself. Therefore, the expression of CD11b and Lselectin on granulocytes in induced sputum cannot be used as marker of disease activity.
